CLINICAL TRIALS PROFILE FOR TWYNSTA
✉ Email this page to a colleague
All Clinical Trials for Twynsta
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01243268 ↗ | A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy | Completed | Boehringer Ingelheim | 2010-12-21 | This is a prospective, observational, open-label, multi-center study, which will provide detailed information about the safety and efficacy of Twynsta tablets in Korean hypertensive patients requiring combination therapy. This will present a convenient treatment option for hypertension in Korean patients. | |
| NCT01316419 ↗ | Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension | Completed | Boehringer Ingelheim | 2011-03-01 | This observational study is designed to evaluate the effects of Twynsta tablets with life style modifications on blood pressure, quality of life, and other risk factors in Korean patients with hypertension in a routine clinical practice setting. | |
| NCT02387619 ↗ | The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine | Completed | Jeil Pharmaceutical Co., Ltd. | Phase 1 | 2015-02-01 | A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic drug interaction between rosuvastatin and telmisartan/amlodipine in healthy male volunteers |
| NCT02496910 ↗ | PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton | Completed | Yuhan Corporation | Phase 1 | 2015-06-01 | This is a Randomized, open-label, single-dose, 2-treatment, 2-period, 2-sequence crossover design. |
| NCT02734355 ↗ | Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation | Completed | Research Institute for Complex Problems of Cardiovascular Diseases, Russia | Phase 4 | 2015-11-01 | The objective of the study was to estimate the efficacy of telmisartan and amlodipine combination on the restoration of left atrial mechanical function after atrial fibrillation catheter ablation. |
| NCT04158076 ↗ | Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine | Completed | Addpharma Inc. | Phase 3 | 2020-01-23 | The purpose of this study is to evaluate the efficacy and safety of co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine in patients with primary hypercholesterolemia and essential hypertension. |
| NCT04667624 ↗ | Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers | Completed | Hanlim Pharm. Co., Ltd. | Phase 1 | 2020-02-29 | A randomized, open label, single dose, 2-sequence, 4-period, cross-over phase I clinical trial to compare and evaluate the safety and pharmacokinetics after oral administration of "LodienT tablet 80/2.5mg(telmisartan/s-amlodipine)" and "TWINSTA tablet 80/5mg(telmisartan/amlodipine)" in healthy adult volunteers. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Twynsta
Condition Name
Clinical Trial Locations for Twynsta
Clinical Trial Progress for Twynsta
Clinical Trial Phase
Clinical Trial Sponsors for Twynsta
Sponsor Name
